KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Basic) (2016 - 2026)

Gilead Sciences filings provide 17 years of EPS (Basic) readings, the most recent being $1.76 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 23.94% to $1.76 in Q4 2025 year-over-year; TTM through Dec 2025 was $6.85, a 1751.35% increase, with the full-year FY2025 number at $6.84, up 1700.0% from a year prior.
  • EPS (Basic) hit $1.76 in Q4 2025 for Gilead Sciences, down from $2.46 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.46 in Q3 2025 to a low of -$3.34 in Q1 2024.
  • Median EPS (Basic) over the past 5 years was $1.25 (2021), compared with a mean of $1.02.
  • Biggest five-year swings in EPS (Basic): soared 3950.0% in 2023 and later tumbled 512.35% in 2024.
  • Gilead Sciences' EPS (Basic) stood at $0.31 in 2021, then surged by 322.58% to $1.31 in 2022, then fell by 12.21% to $1.15 in 2023, then grew by 23.48% to $1.42 in 2024, then grew by 23.94% to $1.76 in 2025.
  • The last three reported values for EPS (Basic) were $1.76 (Q4 2025), $2.46 (Q3 2025), and $1.57 (Q2 2025) per Business Quant data.